This study provides a novel insight of the molecular mechanism and delivery of FADD protein, which can target cancer cell proliferation and NF-κB activation with subsequent suppression of pro-tumorigenic and proinflammatory signaling. The gene discussed is NFKB1; the disease is cancer.